The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis

Bailliere's Best Practice in Clinical Gastroenterology

Volumn 13, Issue 2, 1999, Pages 357-364

  Imrie, C W ^a   McKay, C J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

MODS; Organ failure scores; PAF antagonist therapy; Severe acute pancreatitis; SIRS

Indexed keywords

APROTININ; FRESH FROZEN PLASMA; GABEXATE MESILATE; GLUCAGON; LEXIPAFANT; OCTREOTIDE; PROTEINASE INHIBITOR; SOMATOSTATIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PERITONEUM LAVAGE; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032827851     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0030     Document Type: Article

References (23)